`Case 1:20-cv-05502-AJN Document 133 Filed 06/23/21 Page 1 of 4
`
`IN THE UNITED STATES DISTRICT COURT
`SOUTHERN DISTRICT OF NEW YORK
`
`REGENERON PHARMACEUTICALS, INC.
`
`Plaintiff,
`
`v.
`
`NOVARTIS PHARMA AG, NOVARTIS
`TECHNOLOGY LLC, NOVARTIS
`PHARMACEUTICALS CORPORATION,
`VETTER PHARMA INTERNATIONAL
`GMBH
`
`Defendants.
`
`CASE NO.: 1:20-cv-05502-AJN
`
`Hon. Alison J. Nathan
`
`USDCSDNI'
`lilOCUMENT
`EL£CTRONIC.A1..LY- FILED
`DOC#;. _______ _
`6/23/2021
`
`DAT Fl.LED:
`
`STIPULATION AND [PROPOSED] ORDER MODIFYING CASE SCHEDULE
`
`WHEREAS, Plaintiff Regeneron Pharmaceuticals, Inc. (“Plaintiff”) and Defendants
`
`Novartis Pharma AG, Novartis Technology LLC, Novartis Pharmaceuticals Corporation and
`
`Vetter Pharma International GmbH (collectively, “Defendants”) (Plaintiff and Defendants,
`
`collectively, “Parties”) have been engaged in document discovery in the above-captioned action,
`
`WHEREAS, the Parties agree that they require additional time for substantial completion
`
`of document production,
`
`WHEREAS, the Parties have met and conferred and agreed to seek a one-month extension
`
`of the current deadline for substantial completion of document productions and all remaining
`
`deadlines in the current case schedule (ECF No. 81-2),
`
`IT IS NOW, THEREFORE, HEREBY STIPULATED AND AGREED, by and between
`
`the Parties, through their undersigned attorneys and subject to the Court’s approval, that:
`
`1. The First Amended Case Schedule (ECF No. 81-2) is hereby modified according to the
`
`following Second Amended Case Schedule.
`
`Novartis Exhibit 2096.001
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`~~Jm Cfixlauneeiltl.133.31 Rfleek:01Wil21Zll ~ f45
`
`SECOND AMENDED CASE SCHEDULE
`
`EVENT
`
`CURRENT DATE
`
`AMENDED DATE
`
`Deadline to Serve InteITogatories
`Deadline for Substantial Completion of Document
`Productions
`Deadline to Serve Requests for Admission
`Close of Fact Discove1y
`
`Opening Expe1t Repo1ts Due
`Production of Documents and Data Considered in
`Expe1ts' Repo1ts
`
`Rebuttal Expe1t repo1ts due
`Production of Documents and Data Considered in
`Expe1ts' Repo1ts
`Reply Expe1t reports due
`Production of Documents and Data Considered in
`Expe1ts' Repo1ts
`Close of Expe1t Discove1y
`
`Summaiy Judgment/Daubert Motions Due
`Summaiy Judgment/ Daubert Oppositions Due
`Summaiy Judgment/Daubert Replies Due
`
`July 1, 2021
`
`August 2, 2021
`
`July 1, 2021
`
`August 2, 2021
`
`October 1, 2021
`November 1, 2021
`
`December 13, 2021
`
`November 1, 2021
`
`December 2, 2021
`Janua1y 13, 2022
`
`December 20, 2021
`
`Janua1y 20, 2022
`
`Febrnaiy 7, 2022
`
`March 10, 2022
`
`Febrnaiy 14, 2022
`
`March 1 7, 2022
`
`March 14, 2022
`
`April 14, 2022
`
`March 21, 2022
`
`April 21, 2022
`
`April 14, 2022
`
`May 26, 2022
`July 7, 2022
`August 8, 2022
`
`May 16, 2022
`June 27, 2022
`August 8, 2022
`September 8, 2022
`
`Novartis Exhibit 2096.002
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Case 1 20-cv-05502-AJN Document 131-1 Filed 06/21/21 Page 4 of 5
`Case 1:20-cv-05502-AJN Document 133 Filed 06/23/21 Page 3 of 4
`
`STIPULATED TO AND APPROVED BY:
`
`Dated: June 21, 2021
`
`/s/ Eric S. Hochstadt
`
`Elizabeth Stotland Weiswasser
`Eric S. Hochstadt
`Anish R. Desai (pro hac vice)
`WEIL, GOTSHAL & MANGES LLP
`767 Fifth Avenue
`New York, New York 10153-0119
`Telephone: (212) 310-8000
`Fax: (212) 310-8007
`
`Steven Newborn (pro hac vice)
`Michael R. Moiseyev (pro hac vice)
`WEIL, GOTSHAL & MANGES LLP
`2001 M Street, NW Washington, D.C. 20036
`Telephone: (202) 682-7000
`Fax: (202) 857-0940
`
`Counsel for Plaintiff Regeneron
`Pharmaceuticals, Inc.
`
`/s/ Ian Simmons
`
`Ian Simmons
`Benjamin G. Bradshaw
`O’MELVENY & MYERS LLP
`1625 Eye Street, NW
`Washington, DC 20006
`Telephone: (202) 383-5300
`Facsimile: (202) 383-5414
`
`Lisa B. Pensabene
`O’MELVENY & MYERS LLP
`7 Times Square
`New York, NY 10036
`Telephone: (212) 326-2000
`Facsimile: (212) 326-2061
`
`Stephen J. McIntyre
`O’MELVENY & MYERS LLP
`400 South Hope Street
`Los Angeles, CA 90071
`Telephone: (213) 430-6000
`Facsimile: (213) 430-6407
`
`Counsel for Defendants Novartis Pharma
`AG, Novartis Technology LLC, and
`Novartis Pharmaceuticals Corp.
`
`/s/ Benjamin T. Horton
`
`Benjamin T. Horton
`Julianne M. Hartzell
`MARSHALL GERSTEIN & BORUN LLP
`6300 Willis Tower
`233 S. Wacker Dr.
`Chicago, IL 60606
`T: 312.474.6300
`F: 312.474.0448
`
`Counsel for Defendant Vetter Pharma
`International GmbH
`
`Novartis Exhibit 2096.003
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Case 1:20-cv-05502-AJN Document 133 Filed 06/23/21 Page 4 of 4
`Case 1 20-cv-05502-AJN Document 131-1 Filed 06/21/21 Page 5 of 5
`
`22nd
`IT IS SO ORDERED this ______ day of, ___________2021.
`June
`
`ORDER
`
`~~-~ 1'i'
`
`__________________________________
`The Honorable Alison J. Nathan
`
`Novartis Exhibit 2096.004
`Regeneron v. Novartis, IPR2021-00816
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
